a developer of therapeutics and medicines for central nervous system disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, SAGE has been loosely correlated with RLAY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SAGE jumps, then RLAY could also see price increases.
Ticker / NAME | Correlation To SAGE | 1D Price Change % | ||
---|---|---|---|---|
SAGE | 100% | -6.17% | ||
RLAY - SAGE | 47% Loosely correlated | -4.71% | ||
BEAM - SAGE | 46% Loosely correlated | -8.55% | ||
NTLA - SAGE | 45% Loosely correlated | -3.65% | ||
CRSP - SAGE | 44% Loosely correlated | -4.61% | ||
ALLO - SAGE | 40% Loosely correlated | -4.56% | ||
More |
Ticker / NAME | Correlation To SAGE | 1D Price Change % |
---|---|---|
SAGE | 100% | -6.17% |
SAGE (2 stocks) | 95% Closely correlated | +1.98% |
central nervous system (4 stocks) | 69% Closely correlated | +0.50% |
therapeutics (57 stocks) | 45% Loosely correlated | +20.54% |
pharmaceuticals (167 stocks) | 40% Loosely correlated | +0.82% |